Loading...

LIPIGON CEO AND CO-FOUNDER STEFAN K NILSSON HAS BEEN ELECTED COMMITTEE MEMBER OF PRESTIGOUS EUROPEAN LIPOPROTEIN CLUB

The European Lipoprotein Club (ELC) is the oldest and most active European meeting in the field of lipids. ELC was established in 1977 in order "to promote active participation, collaboration and exchange of ideas concerning basic and clinical research on the structure, function and metabolism of lipoproteins in health and disease". The ELC currently comprises over 500 scientists from more than 20 countries in Europe and abroad, and the number grows every year. The ELC is thus a worldwide network of basic scientists and clinicians involved in lipoprotein research. The network is strengthened and expanded by contacts established at the ELC meetings, and fostered by the exchange of ideas, clinical material, techniques and young visiting investigators “This is a very nice recognition of our research and it feels great to be in the midst of world class science for 5 years (ELC committee member terms). This is not only a personal privilege for me as interested in lipid research but also of great benefit for Lipigon – for both current and future programs” said CEO Stefan K Nilsson.
Read more about ELC here

About Lipigon Pharmaceuticals

Lipigon was founded by leading scientists in the field lipid biology. Lipigon is currently focusing on the discovery and development of first-in-class treatments for lipid related diseases in the orphan space. For more information please visit: www.lipigon.se

For further information, please contact:
Stefan K. Nilsson, CEO, Lipigon Pharmaceuticals
e-mail: stefan@lipigon.se
Tel: +46 70 578 17 68